Herbas VPB

Print
EN | LT
LT - Pakeisti nikotinimido BTK inhibitoriai ir jų preparatai bei naudojimas vėžio, uždegimo ir autoimuninės ligos gydymui
EN - SUBSTITUTED NICOTINIMIDE INHIBITORS OF BTK AND THEIR PREPARATION AND USE IN THE TREATMENT OF CANCER, INFLAMMATION AND AUTOIMMUNE DISEASE

Legal status

Patent in force

Claims | Licences
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 213/81 (2006.01)
C07D 213/84 (2006.01)
C07D 231/36 (2006.01)
C07D 277/56 (2006.01)
C07D 263/34 (2006.01)
C07D 401/14 (2006.01)
C07D 401/04 (2006.01)
C07D 401/12 (2006.01)
C07C 233/65 (2006.01)
A61K 31/4418 (2006.01)
A61K 31/4427 (2006.01)
A61K 31/415 (2006.01)
A61K 31/4155 (2006.01)
A61K 31/426 (2006.01)
A61K 31/421 (2006.01)
A61K 31/4468 (2006.01)
A61K 31/166 (2006.01)
A61P 35/00 (2006.01)
C07D 239/47 (2006.01)
A61K 31/505 (2006.01)
European patent
(11) Number of the document 3052476
(13) Kind of document T
(96) European patent application number 14848083.3
Date of filing the European patent application 2014-09-29
(97) Date of publication of the European application 2016-08-10
(45) Date of publication and mention of the grant of the patent 2020-07-15
(46) Date of publication of the claims translation 2020-10-26
PCT application
(86) Number PCT/US2014/058084
Date 2014-09-29
PCT application publication
(87) Number WO 2015/048662
Date 2015-04-02
Priority applications
(30) Number Date Country code
201361884958 P 2013-09-30 US
201310485048 2013-10-16 CN
Inventors
(72)
CHEN, Xiangyang, CN
GAO, Yingxiang, CN
LIU, Chong, CN
NI, Haihong, CN
MULVIHILL, Mark, US
Grantee
(73) Guangzhou InnoCare Pharma Tech Co., Ltd., Room 899 No. 333 Jiufo Jianshe Road, Sino-Singapore Guangzhou Knowledge City Guangzhou Guangdong 510130, CN
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Pakeisti nikotinimido BTK inhibitoriai ir jų preparatai bei naudojimas vėžio, uždegimo ir autoimuninės ligos gydymui
  SUBSTITUTED NICOTINIMIDE INHIBITORS OF BTK AND THEIR PREPARATION AND USE IN THE TREATMENT OF CANCER, INFLAMMATION AND AUTOIMMUNE DISEASE
Last renewal fee
Payment date Validity (years) Amount
2024-08-19 11 289.00 EUR
Next renewal fee
2025-09-29
Last update date 2024-08-21